2017 Vol.35, N°6 - Suppl.108 - Table of contents

Behçet's Disease and other Autoinflammatory Conditions - No. 17

17th Annual Supplement on Behçet's disease and other Autoinflammatory conditions

Guest Editors: H. Yazici, E. Ben-Chetrit

purchase complete issue

In Memoriam

CER10989
2017,35,6,Suppl.108
Pg. 0002

Free to view

In Memoriam of Ignazio Olivieri
H. Yazici, C. Salvarani

One year in review

CER10780
2017,35,6,Suppl.108
Pg. 0003-0015

Free to view

One year in review 2017: Behçet’s syndrome
G. Hatemi, E. Seyahi, I. Fresko, R. Talarico, V. Hamuryudan

Editorial

CER10627
2017,35,6,Suppl.108
Pg. 0016-0018

Free to view

Can we make a diagnosis of autoinflammatory diseases based upon clinical features only?
E. Ben-Chetrit, H. Ozdogan

Full Papers

CER9166
2017,35,6,Suppl.108
Pg. 0019-0026

Free to view

Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients
S. Yokota, T. Imagawa, R. Nishikomori, H. Takada, K. Abrams, K. Lheritier, T. Heike, T. Hara

CER9295
2017,35,6,Suppl.108
Pg. 0027-0031

Free to view

Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes
S. Bujan-Rivas, M. Basagaña, F. Sena, M. Méndez, M.T. Dordal, E. Gonzalez-Roca, E. Ruiz-Ortiz, A. Mensa-Vilaró, S. Plaza, C. Modesto, J. Ordi-Ros, J. Yagüe, F. Martínez-Valle, J.I. Aróstegui

CER9580
2017,35,6,Suppl.108
Pg. 0032-0037

Free to view

Normal arterial stiffness in familial Mediterranean fever. Evidence for a possible cardiovascular protective role of colchicine
O. Kukuy, A. Livneh, L. Mendel, A. Benor, E. Giat, O. Perski, O. Feld, Y. Kassel, I. Ben-Zvi, M. Lidar, E.J. Holtzman, A. Leiba

CER9906
2017,35,6,Suppl.108
Pg. 0038-0042

Free to view

The prevalence of Behçet’s disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015
J.N. Kim, S.G. Kwak, J.-Y. Choe, S.-K. Kim

CER9811
2017,35,6,Suppl.108
Pg. 0043-0050

Free to view

Behçet's syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status
A.A. Senusi, D. Ola, J. Mather, J. Mather, F. Fortune

CER10159
2017,35,6,Suppl.108
Pg. 0051-0054

Free to view

The prevalence of Behçet’s disease in the north of Jordan: a hospital-based epidemiological survey
W.Y. Madanat, K.M. Alawneh, M.M. Smadi, S.S. Saadeh, M.M. Omari, A.B. Bani Hani, H. Yazici

CER9998
2017,35,6,Suppl.108
Pg. 0055-0059

Free to view

Adherence to guidelines for the treatment of Behçet's syndrome in New York and Amsterdam
F.G. Kerstens, F. Turkstra, S. Atalay, R.M. Van Vugt, C.J. Swearingen, Y. Yazici

CER10182
2017,35,6,Suppl.108
Pg. 0060-0066

Free to view

Cilostazol inhibits the expression of hnRNP A2/B1 and cytokines in human dermal microvascular endothelial cells
Y. An, Z. Zheng, X. Zhang, S.B. Cho, D.Y. Kim, M.J. Choi, D. Bang

CER10144
2017,35,6,Suppl.108
Pg. 0067-0074

Free to view

Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet’s disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein
S.E. Kang, S.J. Lee, J.Y. Lee, H.J. Yoo, J.K. Park, E.Y. Lee, E.B. Lee, Y.W. Song

CER10485
2017,35,6,Suppl.108
Pg. 0075-0081

Free to view

Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF
İ. Karacan, S. Uğurlu, A. Tolun, E. Tahir Turanlı, H. Ozdogan

CER10402
2017,35,6,Suppl.108
Pg. 0082-0085

Free to view

A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controls
M. Lidar, Y. Brantz, Y. Shinar, H. Reznik-Wolf, A. Livneh, I. Ben Zvi, R. Cohen, Y. Berkun, P.J. Hashkes, H. Peleg, A. Kessel, G. Slobodin, M. Rozenbaum, O. Goldzweig, E. Pras

CER10620
2017,35,6,Suppl.108
Pg. 0086-0089

Free to view

Infliximab for uveitis of Behçet’s syndrome: a trend for earlier initiation
G. Guzelant, D. Ucar, S.N. Esatoglu, G. Hatemi, Y. Ozyazgan, S. Yurdakul, E. Seyahi, H. Yazici, V. Hamuryudan

CER10575
2017,35,6,Suppl.108
Pg. 0090-0094

Free to view

Alteration of the microRNA expression profile in familial Mediterranean fever patients
Y.Z. Akkaya-Ulum, B. Balci-Peynircioglu, O. Karadag, F.K. Eroglu, U. Kalyoncu, S. Kiraz, A.I. Ertenli, S. Özen, E. Yilmaz

CER10689
2017,35,6,Suppl.108
Pg. 0095-0099

Free to view

Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruation
G. Guzelant, Y. Ozguler, S.N. Esatoglu, G. Karatemiz, H. Ozdogan, S. Yurdakul, H. Yazici, E. Seyahi

Review

CER10176
2017,35,6,Suppl.108
Pg. 0100-0107

Free to view

Non-invasive vascular biomarkers in patients with Behçet’s disease: review of the data and future perspectives
A.D. Protogerou, E.G. Nasothimiou, P.P. Sfikakis, A.G. Tzioufas

CER10285
2017,35,6,Suppl.108
Pg. 0108-0112

Free to view

The liver in familial Mediterranean fever: is it involved?
E. Ben-Chetrit, H. Yazici

Case Reports

CER9821
2017,35,6,Suppl.108
Pg. 0113-0115

Free to view

Haematological involvement associated with a mild autoinflammatory phenotype, in two patients carrying the E250K mutation of PSTPIP1
E. Belelli, C. Passarelli, M. Pardeo, D. Holzinger, F. De Benedetti, A. Insalaco

CER10367
2017,35,6,Suppl.108
Pg. 0116-0118

Free to view

A case of refractory intestinal Behçet's disease treated with tocilizumab, a humanised anti-interleukin-6 receptor antibody
J. Chen, S. Chen, J. He

Paediatric Rheumatology

CER9810
2017,35,6,Suppl.108
Pg. 0119-0123

Free to view

The performance of different classification criteria in paediatric Behçet’s disease
E.D. Batu, H.E. Sönmez, B. Sözeri, Y. Butbul Aviel, Y. Bilginer, S. Özen

CER10412
2017,35,6,Suppl.108
Pg. 0124-0127

Free to view

Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy
H.E. Sönmez, E.D. Batu, S. Demir, Y. Bilginer, S. Özen

Letters to the Editor

CER9933
2017,35,6,Suppl.108
Pg. 0128-0129

Free to view

Digenic MEFV/TNFRSF1A autoinflammatory syndrome with relapsing aseptic neutrophilic meningitis and chronic myelitis
A. Murarasu, C. Dodé, G. Sarrabay, I. Klein, T. Papo, K. Sacré

CER10336
2017,35,6,Suppl.108
Pg. 0130-0131

Free to view

Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease
G. Lopalco, C. Fabiani, V. Venerito, G. Lapadula, F. Iannone, L. Cantarini

CER10576
2017,35,6,Suppl.108
Pg. 0132

Free to view

Pure red aplasia induced by sodium valproate in a patient with Behçet’s syndrome
P. Leccese, I. Attolico, A. Padula, A. Diplomatico, S. D'angelo, I. Olivieri

CER10481
2017,35,6,Suppl.108
Pg. 0133-0134

Free to view

Autophagy inhibition in adult-onset Still’s disease: still more space for hydroxychloroquine?
C. Papagoras, A. Chrysanthopoulou, A. Mitsios, A. Arampatzioglou, K. Ritis, P. Skendros

CER10833
2017,35,6,Suppl.108
Pg. 0135

Free to view

Recurrent pleural effusion is an important diagnostic clue to distinguish familial Mediterranean fever from Behçet’s disease
F. Yamaguchi, M. Tajika, D. Inoue, Y. Shikama, D. Kishida, A. Nakamura